Keith Goldfeld, member of the Executive Committee of the IMPACT Design & Statistics Core (DSC), is part of the IMPACT Collaboratory study examining the rollout of COVID-19 vaccine in nursing homes. He recently authored a blog post describing the statistical approach to the study.

The effort involves a cluster randomized trial (CRT) to evaluate the effectiveness of a wide-ranging outreach program designed to encourage nursing home residents to get their shots. The focus is on facilities that have relatively high proportions of African-American and Latinx residents, because these facilities have been among the least successful in the past in convincing residents to get vaccinated. The outcome measure of the trial, which will be measured at the individual level, will be the probability of vaccination within 5 weeks of being available at the nursing home.

Read the full blog post at: https://www.rdatagen.net/post/2020-12-22-constrained-randomization-to-evaulate-the-vaccine-rollout-in-nursing-homes/